Institute of Medical Statistics, Informatics and Epidemiology, University of Cologne, Cologne, Germany.
Am J Rhinol Allergy. 2012 Sep-Oct;26(5):e119-25. doi: 10.2500/ajra.2012.26.3787.
Saline nasal irrigation (SNI) is often recommended as additional nonpharmacologic treatment, having proven its efficacy in acute and chronic rhinosinusitis and for therapy after sinonasal surgery. To date, however, no systematic review or meta-analysis exists showing the influence of SNI on allergic rhinitis (AR). This study aimed to establish the impact of SNI on symptoms of AR in different patient groups.
We conducted a systematic search of Medline, Embase, Cochrane Central Register of Controlled Trials, and ISI Web of Science databases for literature published from 1994 to 2010 on SNI in AR. Prospective, randomized, controlled trials that assessed the effects of SNI on four different outcome parameters were included. The evaluation focused on primary (symptom score) and secondary parameters (medicine consumption, mucociliary clearance, and quality of life).
Three independent reviewers chose 10 originals that satisfied the inclusion criteria (>400 participants total) from 50 relevant trials. SNI performed regularly over a limited period of up to 7 weeks was observed to have a positive effect on all investigated outcome parameters in adults and children with AR. SNI produced a 27.66% improvement in nasal symptoms, a 62.1% reduction in medicine consumption, a 31.19% acceleration of mucociliary clearance time, and a 27.88% improvement in quality of life.
SNI using isotonic solution can be recommended as complementary therapy in AR. It is well tolerated, inexpensive, easy to use, and there is no evidence showing that regular, daily SNI adversely affects the patient's health or causes unexpected side effects.
盐水鼻腔冲洗(SNI)常被推荐作为附加的非药物治疗方法,其在急性和慢性鼻-鼻窦炎以及鼻-鼻窦手术后的治疗中已被证实有效。然而,迄今为止,尚无系统评价或荟萃分析显示 SNI 对变应性鼻炎(AR)的影响。本研究旨在确定 SNI 对不同患者群体中 AR 症状的影响。
我们对 Medline、Embase、Cochrane 中心对照试验注册库和 ISI Web of Science 数据库进行了系统检索,以查找 1994 年至 2010 年期间发表的关于 AR 中 SNI 的文献。纳入评估 SNI 对四种不同结局参数影响的前瞻性、随机、对照试验。评估重点为主要(症状评分)和次要参数(药物使用、黏液纤毛清除率和生活质量)。
从 50 项相关试验中,三位独立评审员选择了 10 篇符合纳入标准(总参与者>400 人)的原始研究。在成人和儿童 AR 患者中,观察到在有限的 7 周内定期进行 SNI 治疗对所有调查的结局参数均有积极影响。SNI 可使鼻部症状改善 27.66%,药物使用减少 62.1%,黏液纤毛清除时间加快 31.19%,生活质量提高 27.88%。
使用等渗溶液的 SNI 可作为 AR 的补充治疗方法。其耐受性良好,价格低廉,使用方便,且无证据表明常规每日 SNI 会对患者健康产生不利影响或引起意外的副作用。